Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis

Citation
C. Drobacheff et al., Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis, CLIN CH L M, 39(6), 2001, pp. 519-526
Citations number
35
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
ISSN journal
14346621 → ACNP
Volume
39
Issue
6
Year of publication
2001
Pages
519 - 526
Database
ISI
SICI code
1434-6621(200106)39:6<519:ISASIA>2.0.ZU;2-V
Abstract
The aim of this study was to explore anti-Candida albicans systemic and muc osal humoral responses against Candida virulence antigens such as somatic a ntigen and secreted aspartic proteases (Saps) in HIV-infected patients with oral candidiasis. Twenty-eight subjects were included in the study: 11 HIV-positive patients without oral candidiasis (group A), 6 HIV-positive patients with oral candi diasis (group B) and 11 HIV-negative healthy controls (group C). Total IgA, IgG and IgM concentrations and antibodies to C. albicans (somatic antigen, Sap1, Sap6) were measured in serum and saliva. We developed a time-resolve d immunofluorometric assay with biotin and europium-labeled streptavidin fo r this purpose. Salivary total IgA, IgG and IgM concentrations were higher in group B. IgA, IgG and IgM anti-C. albicans antibodies (against somatic antigen, Sap1, Sa p6) were higher in saliva and serum from patients from group B compared wit h patients from group A and controls. Our results suggest that, in oral candidiasis, HIV-infected patients have a high mucosal response, specifically directed against C. albicans virulence antigens, such as somatic antigen, Sap1 and Sap6.